These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32741633)

  • 1. Commentary: Fear of rejection: Acute cellular rejection after ventricular assist device placement.
    Iyengar A; Smood BF; Atluri P
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):135-136. PubMed ID: 32741633
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Absence of ventricular assist device-related risk for rejection after heart transplantation: Good news given the "new normal".
    Kirklin JK
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):138-139. PubMed ID: 32792153
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient.
    Velez-Martinez M; Rao K; Warner J; Dimaio J; Ewing G; Mishkin JD; Mammen PP; Drazner MH; Markham DW; Patel PC
    Transplant Proc; 2011 Dec; 43(10):3882-4. PubMed ID: 22172864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary graft failure after heart transplantation. Successful recovery with pneumatic biventricular assistance.
    Fernández AL; Herreros JM; Llorens R; Martinez A; Panizo A; Manito N
    Int J Artif Organs; 1996 May; 19(5):307-10. PubMed ID: 8791152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staged approach to mechanical circulatory support and recovered allograft function after transplantation rejection with cardiogenic shock.
    Caceres M; Czer LS; Esmailian F; Luthringer D; Ramzy D; Moriguchi J
    Tex Heart Inst J; 2013; 40(5):596-9. PubMed ID: 24391334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Impella 5L for acute allograft rejection postcardiac transplant.
    Chandola R; Cusimano R; Osten M; Horlick E
    Thorac Cardiovasc Surg; 2012 Jun; 60(4):302-4. PubMed ID: 22547305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy.
    Kaczorowski DJ; Datta J; Kamoun M; Dries DL; Woo YJ
    J Cardiothorac Surg; 2013 Mar; 8():48. PubMed ID: 23497431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biventricular Impella use in pediatric patients with severe graft dysfunction from acute rejection after heart transplantation.
    Ankola AA; McAllister J; Turner ME; Zuckerman WA; Richmond ME; Addonizio LJ; Lee TM; Law SP
    Artif Organs; 2020 Jan; 44(1):100-105. PubMed ID: 31429943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical considerations for cardiac allograft rejection.
    Suarez-Pierre A; Kilic A
    Cardiovasc Pathol; 2019; 42():59-63. PubMed ID: 31351216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of antibody-mediated rejection after cardiac transplantation in a patient supported by a left ventricular assist device for more than 3 years.
    Akiyama M; Takahara S; Kawatsu S; Endo Y; Fujiwara J; Adachi O; Kumagai K; Kawamoto S; Saiki Y
    Gen Thorac Cardiovasc Surg; 2017 Dec; 65(12):710-712. PubMed ID: 28243893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.
    Pagani FD; Dyke DB; Wright S; Cody R; Aaronson KD
    J Heart Lung Transplant; 2001 Jun; 20(6):646-53. PubMed ID: 11404170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe aortic insufficiency secondary to 5L Impella device placement.
    Chandola R; Cusimano R; Osten M; Horlick E
    J Card Surg; 2012 May; 27(3):400-2. PubMed ID: 22621723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.